DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 144 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $765,948 | +7.4% | 60,216 | +18.9% | 0.06% | -10.6% |
| Q2 2023 | $713,335 | +5081.9% | 50,663 | +5586.1% | 0.07% | +2100.0% |
| Q1 2023 | $13,766 | -74.0% | 891 | -68.8% | 0.00% | -66.7% |
| Q3 2022 | $53,000 | – | 2,858 | +142800.0% | 0.01% | – |
| Q2 2022 | $0 | – | 2 | -88.2% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 17 | -97.7% | 0.00% | -100.0% |
| Q4 2021 | $7,000 | – | 743 | – | 0.00% | – |
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
| Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
| Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
| Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
| BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
| AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
| ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
| Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
| EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |